Starling Oncology, Inc. Deferred Tax Liabilities, Gross
Starling Oncology, Inc. (STLN) had Deferred Tax Liabilities, Gross of $7.77 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-12
- 2025-12-31: Deferred Tax Liabilities, Gross $7.77M.
- 2024-12-31: Deferred Tax Liabilities, Gross $9.22M.
- 2023-12-31: Deferred Tax Liabilities, Gross $10.21M.
- 2022-12-31: Deferred Tax Liabilities, Gross $8.70M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $7.77M 10-K · filed 2026-03-12 |
| 2024-12-31 | $9.22M 10-K · filed 2026-03-12 |
| 2023-12-31 | $10.21M 10-K · filed 2025-03-26 |
| 2022-12-31 | $8.70M 10-K · filed 2024-03-28 |
| 2021-12-31 | $2.03M 10-K · filed 2023-03-16 |
| 2020-12-31 | $3.73M 10-K · filed 2022-03-11 |